Skip to content
healthcare.dev

5-Symptom Digestive Relief

NDC 11673-291, Bismuth Subsalicylate, suspension, from TARGET CORPORATION.

Product NDC
11673-291
Status
Listed
Labeler
TARGET CORPORATION
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M008
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11673-291 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BISMUTH SUBSALICYLATE525 mg/30mL
Package NDCNDC-11Package
11673-291-0611673029106236 mL in 1 BOTTLE, PLASTIC (11673-291-06)
11673-291-0711673029107473 mL in 1 BOTTLE, PLASTIC (11673-291-07)
11673-291-08116730291082 BOTTLE, PLASTIC in 1 PACKAGE (11673-291-08) / 473 mL in 1 BOTTLE, PLASTIC (11673-291-07)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 11673-291 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11673-291 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11673-291. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.